Pazopanib (Pazotev)
Pazopanib
Teva Pharmaceuticals (Pty) Ltd
Registration
- Applicant
- Teva Pharmaceuticals (Pty) Ltd
- Certificate holder
- Teva Pharmaceuticals (Pty) Ltd
- Registrations
- 2
- Schedule source
- SAHPRA documentation
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pazotev 200 EACH TABLET CONTAINS PAZOPANIB HYDROCHLORIDE EQUIVALENT TO PAZOPANIB 200,0 mg | 200Film-coated tablets | 57015057/26/0150Approved 18 March 2025 | Registered | S4 | PIPIL |
| Pazotev 400 EACH TABLET CONTAINS PAZOPANIB HYDROCHLORIDE EQUIVALENT TO PAZOPANIB 400,0 mg | 400Film-coated tablets | 57015157/26/0151Approved 18 March 2025 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Pazopanib hydrochloride equivalent to pazopanib
S4: Pazopanib
Consolidated Schedules 06 July 2026, line 7490
Pharmacological class: Cytostatic agents (class 26)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
5-[[4-[(2,3-Dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide
Drag to rotate. Structure from PubChem CID 10113978.
SAHPRA documents
Schedule Verification
This medication's schedule (S4) has been verified from official SAHPRA documents with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.